Blog Posts in July, 2017
-
Update on Testosterone Therapy AndroGel® Trial
Posted By Brett H. Oppenheimer, PLLC$150 Million Verdict Against AbbVie in “Low T” Trial On July 24, 2017, jurors returned a $150 million verdict for the plaintiff in the latest testosterone (“Low T”) trial against manufacturer, AbbVie. Jurors decided that the drug maker fraudulently misrepresented its product, AndroGel®, to the public in its marketing tactics. However, the jurors did not find that AbbVie was responsible or ...Continue Reading -
$110M Jury Award in Another J&J Talcum Powder Ovarian Cancer Case
Posted By Brett H. Oppenheimer, PLLCTalcum powder ovarian cancer lawsuits continue to come in from all around the country, and Johnson & Johnson (J&J) continues to struggle defending itself in court. A recent case out of Missouri has concluded with a jury awarding a Virginia woman a grand total of $110 million in total awards. The 62-year old was diagnosed with ovarian cancer in 2012 and alleged that J&J intentionally misled ...Continue Reading -
Tort Reform in Kentucky: Medical Malpractice Case Changes & More
Posted By Brett H. Oppenheimer, PLLCKentucky’s medical malpractice claim procedures will soon be subjected to higher scrutiny due to recently approved tort reform. Whenever a medical malpractice claim is filed in the state, a three-doctor panel backed by a supervising attorney will need to review the case for validity. If the panel does not approve the claim, it will not reach courts. The panel, which will first start reviewing ...Continue Reading
Page
1 of 1